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Identity 
Other names: BRIT1; MCT 
HGNC (Hugo): MCPH1 
Location: 8p23.1 
Local order: According to NCBI Map Viewer, genes 
flanking MCPH1 in telomere to centromere direction 
on 8p23.1 are: ANGPT2 (angiopoietin 2); MCPH1 
(also BRIT1); AGPAT5 (1-acylglycerol-3-phosphate 
O-acyltransferase 5 (lysophosphatidic acid 
acyltransferase, epsilon)); XKR5 (XK, Kell blood 
group complex subunit-related family, member 5); 
DEFB1 (defensin, beta 1); DEFA6 (defensin, alpha 6, 
Paneth cell-specific). 
Note 
MCPH1 is one of DNA damage response proteins that 
interact with other DNA damage and repair proteins 
and signal transducers, form a DNA damage response 
protein complex which can be seen through 
immunofluorescent microscopy, and participate into 
DNA repair, cell cycle checkpoint control, and 
eventually maintain genomic integrity. The aberrant 
expression of MCPH1 is observed in ovarian cancer 
and breast cancer tissues and cell lines. Thus, 
functional impairment of MCPH1 may significantly 
contribute to tumour susceptibility  
and/or tumour development. In addition, indivi-duals 
who harbor a germline mutation of MCPH1 gene may 
be highly susceptible to an autosomal recessive 
neurological disorder, called primary microcephaly. 
DNA/RNA 
Description 
According to Entrez-Gene, MCPH1 gene maps to 
NC_000008.9 in the region between 6251529 and 
6493434 on the plus strand and spans across 241.9 kilo 
bases. According to GenBank, MCPH1 has 14 exons, 
the sizes being 90, 92, 119, 88, 115, 144, 90, 1155, 10, 
38, 163, 78, 238, and 5512 bp. 
Transcription 




MCPH1 has three BRCA1 carboxyl-terminal (BRCT) 
domains, so it is regarded as a protein family member 
involved in DNA damage repair and checkpoint 
control. 
 
The protein of MCPH1 contains three BRCT domains, the nuclear localization signal motif and the large middle IMPDH domain. (AA, 
amino acids). 
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Description 
MCPH1 protein contains 835 amino acids with about 
110 kDa of the molecular weight. According to 
MotifScan prediction, MCPH1 has three BRCT 
domains, one nuclear localization signal motif and the 
large central IMPDH domain as depicted in the 
diagram above. The BRCT domains of MCPH1, one in 
N-terminus (N-BRCT), the other two tandemly 
arranged in C-terminus (C-BRCTs), specifically bind to 
the phosphorylated proteins commonly involved in 
DNA damage response pathways. The N-BRCT is 
required for centrosomal localization in irradiated cells, 
and also essential to rescue the premature chromosome 
condensation in MCPH1-deficient cells. C-BRCTs 
direct self-oligo-merization of MCPH1, and are 
necessary for ionizing radiation-induced foci formation. 
The function of IMPDH domain predicted by 
MotifScan is not clear yet. However, the region 
(residues 376-485) in the central IMPDH domain (or 
middle domain), binding with Condension II, 
participates in homologous recombination. 
Expression 
MCPH1 is ubiquitously expressed in human with the 
higher levels observed in the brain, testes, pancres and 
liver. It is a putative tumor suppressor and the abrrant 
expression of MCPH1 is correlated with ovarian and 
breast cancer. This reduced expression of MCPH1 may 
have been caused by gene deletion detected by high-
density array comparative genomic hybridization 
(CGH). 
Localisation 
Mainly localized in nucleus. 
Function 
MCPH1 function in DNA damage response: MCPH1 
can modulate activities of two distinct DNA damage 
repair networks, the ATM (ataxia telangiectaisia 
mutated) pathway and the ATR (ATM and Rad3-
related) pathway. Upon exposure to DNA damaging 
reagents, MCPH1 co-localizes with numerous proteins 
associated with these two signaling pathways including 
gamma-H2AX, MDC1, 53BP1, NBS1, p-ATM, ATR, 
p-RAD17 and p-RPA34. In the absence of MCPH1, all 
of these proteins with the exception of gamma-H2AX, 
fail to localize to sites of DNA damage. The depletion 
of MCPH1 inhibits the recruitment of phosphorylated 
ATM to double-stranded DNA break ends, and 
subsequently impair t phosphory-lation of multiple 
down-stream members of the ATM pathway. MCPH1 
deficiency also abolishes the UV-induced 
phosphorylation of RPA34 and reduces the levels of 
phosphorylated RAD17, suggesting the roles of 
MCPH1 in the ATR path-way. Rad51, a homolog of 
the bacterial RecA, is a central executioner in 
homologous recombination (HR), catalyzing the 
invasion of the single stranded DNA in a homologous  
duplex and facilitating the homology search during the
establishment of joint molecules. Lack of MCPH1 can 
alleviate localization of RAD51 onto the DNA break 
sites. So MCPH1 is strongly implicated in HR. 
Role of BRIT1 in cell cycle control: MCPH1 has been 
demonstrated to regulate the expression of BRCA1 and 
Chk1 and required for activation of intra-S and G2/M 
cell cycle checkpoint after cellular exposure to ionizing 
radiation. In the absence of MCPH1, BRCA1 and 
ChK1 expression is significantly reduced and NBS1 
fails to be phosphorylated, leading to loss of intra-S and 
G2/M checkpoint control. Cells derived from a micro-
cephaly patient (MCPH1 defective) maintain a 
persistent level of CDC25A and reduced level of Cdk1-
cyclin B complex, both of which attributes to entry of 
mitosis. So besides expression control of ChK1 and 
BRCA1, MCPH1 prevents premature entry into mitosis 
in an ATR-dependent and ATR-independent manner. 
Homology 
According to NCBI-HomoloGene: 
Chimpanzee (Pan troglodytes): MCPH1 
(NP_001009010.1, 835 aa) 
Dog (Canis familiaris): MCPH1 (NP_001003366.1, 
850 aa) 
Rat (Rattus norvegicus): MCPH1 (XP_225006.4, 986 
aa) 
Mouse (Mus musculus): MCPH1 (NP_775281.2, 822 
aa) 
Zebrafish (Danio rerio): zgc:136403 (NP_001035453.1, 
422 aa) 
Drosophila (Drosophila melanogaster): CG30038 
(NP_725086.2, 219 aa) 
Mutations 
Note 
Three point mutations in the autosomal recessive 
mental retardation patients have been described for 
MCPH1 so far. Two mutations (S25X and 427insA) 
lead to premature stop condon, and one (T27R) leads to 
missense mutation in the N-terminal BRCT domain. A 
non-synonymous SNP (V761A in BRCA1 C-terminus 
(BRCT) domain) of MCPH1 is significantly associated 
with cranial volume in Chinese males. In addition, a 
deletion of approximately 150-200 kb, encompassing 
the promoter and the first six exons of the MCPH1 
gene, was revealed by Array-based homozygosity 
mapping and high-resolution microarray-based 
comparative genomic hybridization (array CGH). 
However, the patients with this deletion just showed 




Aberrations of MCPH1 have been identified in various 
human cancers. 
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Disease 
MCPH1 DNA copy number was substatially decreased 
in 40% of advanced epithelial ovarian cancer, and its 
mRNA levels were also dramatically decreased in 63% 
of ovarian cancer. 
Breast cancers 
Disease 
MCPH1 mRNA and protein levels was aberrantly 
reduced in several breast cancer cell lines. 
Prognosis 
Additionally, reduced MCPH1 expression correla-ted 
with the duration of the relapse-free intervals and with 
the occurrence of metastasis in breast cancers. BRIT1 
deficiency may contribute to development and 
aggressive nature of breast tumors. 
Primary microcephaly 
Disease 
Primary microcephaly is an autosomal recessive 
disorder, in which there is a marked reduction in brain 
size. One form of primary microcephaly, MCPH, is 
caused by mutation in the gene encoding microcephalin 
1 (that is, MCPH1). In these patients, the MCPH1-
deficient cells show cellular phenotype of premature 
chromosome condensation in the early G2 phase of the 
cell cycle, which, therefore, appears to be a useful 
diagnostic marker for these individuals. As mentioned 
above, several mutations of MCPH1 have been 
observed in these patients, including S25X, 427insA, 
T27R, V761A and 5'-deletion of a large portion 
encompassing the promoter region and first six exons, 




Premature chromosome condensation (PCC) syndrome 
is characterized by premature chromosome 
condensation in the early G2 phase. This disorder is 
similar to microcephalin 1, and can also be caused by 
MCPH1 mutations. 
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